lexiara

Schedule 3C, Part 3, paragraph 15(2)

Other irritating chemical substances, and mixtures thereof containing at least 0.3 % by weight of the active substance, as follows, except where the material is incorporated in a medical product— Note: For the purposes of paragraph (2) which precedes this table, “medical product” means— (1) a pharmaceutical formulation designed for human administration in the treatment of medical conditions, and (2) prepackaged for distribution as a clinical or medical product.

· All articles ·

Source: legislation.gov.uk · retrieved 2026-08-30